Is France's Drug Dilemma a Lesson on Price Control Pitfalls?

In France, a textbook case of economic intervention gone awry is unfolding. The government-imposed price control measures intended to make medications affordable for everyone have backfired, leading to critical drug shortages across the nation. This scenario perfectly illustrates the dangers of bureaucratic meddling in free markets. When governments set artificially low prices, they disincentivize manufacturers, creating scarcity instead of abundance. Now, France finds itself grappling with the unintended consequences of its well-meaning but ultimately flawed policies. The lesson? Sometimes the cure is worse than the disease.